Publications by authors named "Daniel Spratt"

Claim this Profile
S
Stereotactic Intensity-modulated Radiotherapy After Radical Prostatectomy (SCIMITAR): 4-Year Outcomes of a Phase 2 Clinical Trial.
Amar U Kishan, Jesus E Juarez Casillas, Paul Sargos, Tahmineh Romero Kalbasi, Sylvie Chabaud, Daniel Spratt

Eur Urol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of 17β-Estradiol Administration by Subcutaneous Injections in Transgender Women.
Hadley M Moreau, Haley Perkins, Jennifer LaBudde, Wendy Y Craig, Daniel I Spratt

J Endocr Soc· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of race and survival in patients treated with apalutamide: Pooled analysis of two phase 3 trials.
Georges Gebrael, Neeraj Agarwal, Alicia K Morgans, Randy Vince, Umang Swami, Daniel E Spratt

Cancer· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 3 Trial of Dose-Escalated Radiation Therapy and Standard Androgen Deprivation Therapy Versus Dose-Escalated Radiation Therapy and Enhanced Androgen Deprivation Therapy With Orteronel for Men With High-Risk Prostate Cancer (NRG/RTOG 1115).
Daniel A Hamstra, James J Dignam, Deborah W Bruner, M Dror Michaelson, François Bachand, Daniel E Spratt

Int J Radiat Oncol Biol Phys· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physician Body-Site Expertise and Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy Rounds Review.
Elizabeth Covington, Krithika Suresh, Aleksandar Dragovic, Mary Feng, Jason Hearn, Daniel Spratt

Adv Radiat Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancer.
Udit Singhal, Ralph Jiang, James A Proudfoot, Elizabeth Chase, Krithika Suresh, Daniel E Spratt

Prostate Cancer Prostatic Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer.
Soumyajit Roy, Yilun Sun, Maha Hussain, Kim N Chi, Karim Fizazi, Daniel E Spratt

Nat Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of a Multimodal Artificial Intelligence-derived Digital Pathology-based Biomarker Predicting Metastasis Among Patients with Biochemical Recurrence After Radical Prostatectomy in NRG/RTOG Trials.
Todd M Morgan, Yi Ren, Siyi Tang, Wouter Zwerink, Emmalyn Chen, Daniel E Spratt

Eur Urol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age and Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer.
Alicia K Morgans, Soumyajit Roy, Angela Y Jia, Pedro Barata, Nicholas G Zaorsky, Daniel E Spratt

NEJM Evid· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate Cancer, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology.
Daniel E Spratt, Sandy Srinivas, Nabil Adra, Bilawal Ahmed, Yi An

J Natl Compr Canc Netw· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heart Disease Mortality After Primary Cancer Surgery in the United States.
Jessica J Bai, Kyle A Mani, Daxuan Deng, Luke Rothermel, Jonathan Shoag, Daniel E Spratt

Am J Clin Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatial multi-omics identifies aggressive prostate cancer signatures highlighting pro-inflammatory chemokine activity in the tumor microenvironment.
Sebastian Krossa, Maria K Andersen, Elise M Sandholm, Maximilian Wess, Antti Kiviaho, Daniel E Spratt

Nat Commun· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal Duration of Androgen Deprivation Therapy With Definitive Radiotherapy for Localized Prostate Cancer: A Meta-Analysis.
Nicholas G Zaorsky, Yilun Sun, Abdenour Nabid, Almudena Zapatero, Michel Bolla, Daniel E Spratt

JAMA Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers.
Emily Grist, Peter Dutey-Magni, Marina A Parry, Larissa Mendes, Ashwin Sachdeva, Daniel E Spratt

Cell· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revisiting prostate cancer active surveillance candidacy.
Daniel E Spratt, Edward M Schaeffer

Lancet Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate Data.
Sarah Burdett, David J Fisher, Jayne F Tierney, Adrian D Cook, Daniel E Spratt

Eur Urol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
oDigital pathology biomarkers for guiding radiotherapy-based treatment concepts in prostate cancer - a systematic review and expert consensus.
Constantinos Zamboglou, William De Doncker, Andreas Thomas Christoforou, Stefano Arcangeli, Alejandro Berlin, Daniel E Spratt

Radiother Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individual income and race-associated differences in prostate cancer mortality in a statewide registry.
Alec Zhu, Stephen Rhodes, Bashir Al Hussein Al Awamlh, Randy A Vince, Nicholas Zaorsky, Daniel E Spratt

JNCI Cancer Spectr· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptomic Analysis of Localized High-risk Prostate Cancer Improves Prognostication and Identifies Benefit from Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase 3 Trial.
Ryan M Phillips, James A Proudfoot, Elai Davicioni, Yang Liu, Daniel E Spratt

Eur Urol Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statin Use in Patients With Advanced Prostate Cancer in the TITAN and SPARTAN Trials.
Soumyajit Roy, Zeynep Irem Ozay, Avirup Guha, Yilun Sun, Kim N Chi, Daniel E Spratt

JAMA Netw Open· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External validation of a digital pathology-based multimodal artificial intelligence-derived prognostic model in patients with advanced prostate cancer starting long-term androgen deprivation therapy: a post-hoc ancillary biomarker study of four phase 3 randomised controlled trials of the STAMPEDE platform protocol.
Charles T A Parker, Larissa Mendes, Vinnie Y T Liu, Emily Grist, Songwan Joun, Daniel E Spratt

Lancet Digit Health· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of Image Guidance and Adaptive Radiation Therapy for Localized Prostate Cancer.
Rohan K Patel, Joan Lee, Maitry Patel, Nicholas G Zaorsky, Raed Zuhour, Daniel E Spratt

Int J Radiat Oncol Biol Phys· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy- Versus Surgery-based Treatment Strategy in High-risk Prostate Cancer.
Soumyajit Roy, Yilun Sun, James A Eastham, Martin Gleave, Christopher J D Wallis, Daniel E Spratt

Eur Urol Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing Stemness Drives Prostate Cancer Progression, Plasticity, Therapy Resistance and Poor Patient Survival.
Xiaozhuo Liu, Eduardo Cortes, Yibing Ji, Kathy Zhao, Julian Ho, Daniel E Spratt

bioRxiv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-Comparison Individual Patient-Level Analysis of Three Gene Expression Signatures in Localized Prostate in Over 50,000 Men.
Angela Y Jia, Yilun Sun, Maitry Patel, Atallah Baydoun, Randy A Vince, Daniel E Spratt

JCO Precis Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis